Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationStem CellsGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationHematopoiesisBone Marrow TransplantationTransplantation ChimeraStem Cell NicheHistocompatibility TestingTissue DonorsCell DifferentiationTreatment OutcomeAntigens, CD34Hepatic Veno-Occlusive DiseaseAdult Stem CellsLeukemiaCell LineageBone Marrow CellsEmbryonic Stem CellsCord Blood Stem Cell TransplantationHematopoietic Stem Cell MobilizationMice, Inbred C57BLTransplantationGraft SurvivalImmunosuppressive AgentsRetrospective StudiesMyeloablative AgonistsWhole-Body IrradiationFlow CytometryBone MarrowBusulfanHLA AntigensColony-Forming Units AssayMesenchymal Stem Cell TransplantationHistocompatibilityImmunocompromised HostFetal BloodPancytopeniaChimerismGraft vs Leukemia EffectLiver TransplantationRecurrenceAnemia, AplasticCells, CulturedPluripotent Stem CellsCell ProliferationHematologic DiseasesRemission InductionCombined Modality TherapyCell TransplantationMultiple MyelomaMultipotent Stem CellsTime FactorsMesenchymal Stromal CellsLeukemia, Myeloid, AcuteSiblingsNeural Stem CellsVidarabineUnrelated DonorsStem Cell FactorMyelodysplastic SyndromesFollow-Up StudiesSurvival RateInduced Pluripotent Stem CellsGraft vs Tumor EffectDisease-Free SurvivalMelphalanTransplantation ImmunologySurvival AnalysisSevere Combined ImmunodeficiencyLymphocyte TransfusionCell CountKidney TransplantationGranulocyte Colony-Stimulating FactorCyclophosphamideStromal CellsTransplantation, IsogeneicCell SeparationFetal Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaSalvage TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsAntilymphocyte SerumDonor SelectionT-LymphocytesAntineoplastic Combined Chemotherapy ProtocolsLymphocyte DepletionAllograftsAcute DiseaseGraft RejectionMice, SCIDCell Culture TechniquesSignal Transduction